Aurovela 1/20 Interactions
There are 469 drugs known to interact with Aurovela 1/20 (ethinyl estradiol/norethindrone), along with 24 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 66 are major, 355 are moderate, and 48 are minor.
- View all 469 medications that may interact with Aurovela 1/20
- View Aurovela 1/20 alcohol/food interactions (8)
- View Aurovela 1/20 disease interactions (24)
Most frequently checked interactions
View interaction reports for Aurovela 1 / 20 (ethinyl estradiol / norethindrone) and the medicines listed below.
- fexofenadine
- Flonase (fluticasone nasal)
- Kaopectate (bismuth subsalicylate)
- Lomotil (atropine / diphenoxylate)
- loperamide
- metformin
- Ozempic (semaglutide)
- spironolactone
- Trintellix (vortioxetine)
- Tylenol (acetaminophen)
Aurovela 1/20 alcohol/food interactions
There are 8 alcohol/food interactions with Aurovela 1 / 20 (ethinyl estradiol / norethindrone).
Aurovela 1/20 disease interactions
There are 24 disease interactions with Aurovela 1 / 20 (ethinyl estradiol / norethindrone) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
Report options
More about Aurovela 1 / 20 (ethinyl estradiol / norethindrone)
- Aurovela 1/20 consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: contraceptives
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.